Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
August 24, 2026 by regulatorwatch.com
Major Win | Court Ruling Could Dismantle FDA’s Flavored Vape Ban | RegWatch
The court ruling against the FDA’s approach to flavoured vapes could mark an important turning point for evidence-based regulation. Flavours are not a minor detail for many adults who switch from smoking; they can affect whether lower-risk products are acceptable enough to replace cigarettes. Youth protection remains essential, but it should be pursued through enforcement and product standards rather than blanket hostility to adult choice. A credible regulatory system should assess risk, behaviour and public health impact instead of treating flavour as automatic failure.
August 24, 2026 by goodgoodgood.co
Smoking rates reach historic low among youth in the United States
Historic-low youth smoking rates should be recognised as major public health progress. The latest US data also show falling youth vaping, challenging the idea that adult access to lower-risk nicotine products inevitably drives a youth crisis. Prevention still matters, especially for those who already vape frequently, but the message should be proportionate. Protecting young people and helping adult smokers leave cigarettes behind can be part of the same strategy.
August 20, 2026 by theconversation.com
US teens are smoking and vaping less than their peers abroad
Lower youth smoking and vaping rates in the US deserve attention because they challenge the assumption that harm reduction for adults must come at the cost of youth protection. The real question is what policies, norms and enforcement patterns are helping to reduce adolescent use while still recognising that adult smokers need alternatives to cigarettes. Youth prevention and adult harm reduction should not be treated as opposing goals. A serious nicotine strategy has to protect young people without distorting the risk message for everyone else.
August 19, 2026 by gfn.tv
Can Governments Enforce Their Way Out of the Illicit Market Crisis? | #GFN Voices 2026 #4
Enforcement cannot fix a market that policy itself is helping to create. Illicit nicotine trade grows where demand remains high, legal access is restricted and safer products are pushed outside accountable channels. Police action may disrupt supply, but it cannot remove the incentives that make illegal sales profitable. A serious response to the illicit market crisis has to combine enforcement with harm reduction, realistic regulation and legal options that adults will actually use.
August 18, 2026 by smokefreesweden.org
Doctor’s orders: Offer vapes to smokers as quitting tool
A JAMA publication should raise the standard of the nicotine debate, not narrow it into alarm. Research on smoking, vaping or smoke-free products needs to be read through the lens of comparison: what happens to people who continue smoking, switch completely, or use products alongside cigarettes. The public health value lies in that distinction. Evidence should clarify the movement away from combustion, not be used to make every nicotine product appear equally harmful.
August 14, 2026 by thewellnews.com
New Research Blows Up the Myths Driving Vaping Bans
Vaping bans are often built on claims that sound settled but weaken under closer scrutiny. New research challenges the assumptions used to justify prohibition, especially around youth use, switching and the role of flavours for adults who smoke. Evidence should be allowed to disturb comfortable policy narratives. Public health cannot reduce harm by defending myths that make lower-risk alternatives harder to access.
August 14, 2026 by substack.com
NHS goes "merchant of doubt" on vaping as an alternative to smoking
A smoker looking for NHS advice deserves clarity, not mixed signals. Vaping carries uncertainty, but cigarettes carry a far greater and well-established burden of harm. Presenting caution without proportion can make the lower-risk option seem too doubtful to trust. Public health guidance should help people understand the direction of risk clearly enough to act on it.
August 13, 2026 by disobedientmargins.com
When What Burns Seems Cleaner Than What Produces No Smoke
When the product that burns begins to look “cleaner” than the product that reduces smoke exposure, something has gone wrong in public understanding. Risk perception can be distorted by language, imagery and regulation until cigarettes feel familiar while safer alternatives feel suspect. That inversion matters because smokers may avoid switching if the lower-risk option is framed as the greater threat. Public health should correct that confusion, not reinforce it.
August 12, 2026 by regulatorwatch.com
Playing Offense | U.S. Vape Industry Rejects All-or-Nothing Regulation | RegWatch
All-or-nothing regulation leaves little room for the adults caught between smoking and quitting. The US vape industry’s pushback reflects a broader problem: when legal products are treated as unacceptable unless they meet impossible standards, cigarettes remain the most stable option on the market. Regulation should demand responsibility, evidence and enforcement without closing the door on products that help smokers switch. Public health needs standards that reduce harm, not rules that make only prohibition seem acceptable.
August 12, 2026 by regulatorwatch.com
Playing Offense | U.S. Vape Industry Rejects All-or-Nothing Regulation | RegWatch
All-or-nothing regulation leaves little room for the adults caught between smoking and quitting. The US vape industry’s pushback reflects a broader problem: when legal products are treated as unacceptable unless they meet impossible standards, cigarettes remain the most stable option on the market. Regulation should demand responsibility, evidence and enforcement without closing the door on products that help smokers switch. Public health needs standards that reduce harm, not rules that make only prohibition seem acceptable.